|
1
|
WHO report 2019, https://apps.who.int/iris/bitstream/handle/10665/329368/9789241565714-eng.pdf.
|
|
2
|
Polena H, Boudou F, Tilleul S,
Dubois-Colas N, Lecointe C, Rakotosamimanana N, Pelizzola M,
Andriamandimby SF, Raharimanga V, Charles P, et al: Mycobacterium
tuberculosis exploits the formation of new blood vessels for its
dissemination. Sci Rep. 6(33162)2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Golden MP and Vikram HR: Extrapulmonary
tuberculosis: An overview. Am Fam Physician. 72:1761–1768.
2005.PubMed/NCBI
|
|
4
|
Russell DG, Barry CE III and Flynn JL:
Tuberculosis: What we don't know can, and does, hurt us. Science.
328:852–856. 2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Dartois V: The path of anti-tuberculosis
drugs: From blood to lesions to mycobacterial cells. Nat Rev
Microbiol. 12:159–167. 2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Oehlers SH, Cronan MR, Scott NR, Thomas
MI, Okuda KS, Walton EM, Beerman RW, Crosier PS and Tobin DM:
Interception of host angiogenic signalling limits mycobacterial
growth. Nature. 517:612–615. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Dvorak HF, Brown LF, Detmar M and Dvorak
AM: Vascular permeability factor/vascular endothelial growth
factor, microvascular hyperpermeability, and angiogenesis. Am J
Pathol. 146:1029–1039. 1995.PubMed/NCBI
|
|
8
|
Jain RK: Normalizing tumor vasculature
with anti-angiogenic therapy: A new paradigm for combination
therapy. Nat Med. 7:987–989. 2001.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Chackerian AA, Alt JM, Perera TV, Dascher
CC and Behar SM: Dissemination of Mycobacterium tuberculosis is
influenced by host factors and precedes the initiation of T-cell
immunity. Infect Immun. 70:4501–4509. 2002.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Davis JM and Ramakrishnan L: The role of
the granuloma in expansion and dissemination of early tuberculous
infection. Cell. 136:37–49. 2009.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Monin L and Khader SA: Chemokines in
tuberculosis: The good, the bad and the ugly. Semin Immunol.
26:552–558. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Keeley EC, Mehrad B and Strieter RM:
Chemokines as mediators of neovascularization. Arterioscler Thromb
Vasc Biol. 28:1928–1936. 2008.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Perez AL, Bachrach E, Illigens BM, Jun SJ,
Bagden E, Steffen L, Flint A, McGowan FX, Del Nido P,
Montecino-Rodriguez E, et al: CXCR4 enhances engraftment of muscle
progenitor cells. Muscle Nerve. 40:562–572. 2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Hoshino Y, Tse DB, Rochford G, Prabhakar
S, Hoshino S, Chitkara N, Kuwabara K, Ching E, Raju B, Gold JA, et
al: Mycobacterium tuberculosis-induced CXCR4 and chemokine
expression leads to preferential X4 HIV-1 replication in human
macrophages. J Immunol. 172:6251–6258. 2004.PubMed/NCBI View Article : Google Scholar
|
|
15
|
García-Cuesta EM, Santiago CA,
Vallejo-Díaz J, Juarranz Y, Rodríguez-Frade JM and Mellado M: The
role of the CXCL12/CXCR4/ACKR3 axis in autoimmune diseases. Front
Endocrinol (Lausanne). 10(585)2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gil M, Seshadri M, Komorowski MP, Abrams
SI and Kozbor D: Targeting CXCL12/CXCR4 signaling with oncolytic
virotherapy disrupts tumor vasculature and inhibits breast cancer
metastases. Proc Natl Acad Sci USA. 110:E1291–E1300.
2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Peled A, Abraham M, Avivi I, Rowe JM,
Beider K, Wald H, Tiomkin L, Ribakovsky L, Riback Y, Ramati Y, et
al: The high-affinity CXCR4 antagonist BKT140 is safe and induces a
robust mobilization of human CD34+ cells in patients with multiple
myeloma. Clin Cancer Res. 20:469–479. 2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Beider K, Begin M, Abraham M, Wald H,
Weiss ID, Wald O, Pikarsky E, Zeira E, Eizenberg O, Galun E, et al:
CXCR4 antagonist 4F-benzoyl-TN14003 inhibits leukemia and multiple
myeloma tumor growth. Exp Hematol. 39:282–292. 2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Salcedo R, Wasserman K, Young HA, Grimm
MC, Howard OM, Anver MR, Kleinman HK, Murphy WJ and Oppenheim JJ:
Vascular endothelial growth factor and basic fibroblast growth
factor induce expression of CXCR4 on human endothelial cells: In
vivo neovascularization induced by stromal-derived factor-1alpha.
Am J Pathol. 154:1125–1135. 1999.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Davuluri KS, Singh AK, Kumar V, Singh SV,
Singh AV, Kumar S, Yadav R, Kushwaha S and Chauhan DS: Stimulated
expression of ELR+ chemokines, VEGFA and TNF-AIP3 promote
mycobacterial dissemination in extrapulmonary tuberculosis patients
and Cavia porcellus model of tuberculosis. Tuberculosis (Edinb).
135(102224)2022.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Klinkenberg LG, Lee JH, Bishai WR and
Karakousis PC: The stringent response is required for full
virulence of Mycobacterium tuberculosis in guinea pigs. J Infect
Dis. 202:1397–1404. 2010.PubMed/NCBI View
Article : Google Scholar
|
|
22
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals. Guide for the care and use of laboratory animals. 8th
edition. Washington (DC): National Academies Press (US), 2011.
|
|
23
|
Kashino SS, Napolitano DR, Skobe Z and
Campos-Neto A: Guinea pig model of Mycobacterium tuberculosis
latent/dormant infection. Microbes Infect. 10:1469–1476.
2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Fischer AH, Jacobson KA, Rose J and Zeller
R: Hematoxylin and eosin staining of tissue and cell sections. CSH
Protoc. 2008(pdb.prot4986)2008.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kim SW, Roh J and Park CS:
Immunohistochemistry for pathologists: Protocols, pitfalls, and
tips. J Pathol Transl Med. 50:411–418. 2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Goutal S, Auvity S, Legrand T, Hauquier F,
Cisternino S, Chapy H, Saba W and Tournier N: Validation of a
simple HPLC-UV method for rifampicin determination in plasma:
Application to the study of rifampicin arteriovenous concentration
gradient. J Pharm Biomed Anal. 123:173–178. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Aït Moussa L, El Bouazzi O, Serragui S,
Soussi Tanani D, Soulaymani A and Soulaymani R: Rifampicin and
isoniazid plasma concentrations in relation to adverse reactions in
tuberculosis patients: A retrospective analysis. Ther Adv Drug Saf.
7:239–247. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Sia JK and Rengarajan J: Immunology of
Mycobacterium tuberculosis Infections. Microbiol Spectr 7:
10.1128/microbiolspec.GPP3-0022-2018, 2019.
|
|
30
|
Torraca V, Tulotta C, Snaar-Jagalska BE
and Meijer AH: The chemokine receptor CXCR4 promotes granuloma
formation by sustaining a mycobacteria-induced angiogenesis
programme. Sci Rep. 7(45061)2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ramonell KM, Zhang W, Hadley A, Chen CW,
Fay KT, Lyons JD, Klingensmith NJ, McConnell KW, Coopersmith CM and
Ford ML: CXCR4 blockade decreases CD4+ T cell exhaustion and
improves survival in a murine model of polymicrobial sepsis. PLoS
One. 12(e0188882)2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Reyes AWB, Arayan LT, Huy TXN, Vu SH, Kang
CK, Min W, Lee HJ, Lee JH and Kim S: Chemokine receptor 4 (CXCR4)
blockade enhances resistance to bacterial internalization in
RAW264.7 cells and AMD3100, a CXCR4 antagonist, attenuates
susceptibility to Brucella abortus 544 infection in a murine model.
Vet Microbiol. 237(108402)2019.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Pozzobon T, Goldoni G, Viola A and Molon
B: CXCR4 signaling in health and disease. Immunol Lett. 177:6–15.
2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Mirabelli P, Mukwaya A, Lennikov A,
Xeroudaki M, Peebo B, Schaupper M and Lagali N: Genome-wide
expression differences in anti-Vegf and dexamethasone treatment of
inflammatory angiogenesis in the rat cornea. Sci Rep.
7(7616)2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Mousavi A: CXCL12/CXCR4 signal
transduction in diseases and its molecular approaches in
targeted-therapy. Immunol Lett. 217:91–115. 2020.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Liang Z, Brooks J, Willard M, Liang K,
Yoon Y, Kang S and Shim H: CXCR4/CXCL12 axis promotes VEGF-mediated
tumor angiogenesis through Akt signaling pathway. Biochem Biophys
Res Commun. 359:716–722. 2007.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Kawaguchi N, Zhang TT and Nakanishi T:
Involvement of CXCR4 in normal and abnormal development. Cells.
8(185)2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wright K, de Silva K, Plain KM, Purdie AC,
Blair TA, Duggin IG, Britton WJ and Oehlers SH: Mycobacterial
infection-induced miR-206 inhibits protective neutrophil
recruitment via the CXCL12/CXCR4 signalling axis. PLoS Pathog.
17(e1009186)2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Philips JA and Ernst JD: Tuberculosis
pathogenesis and immunity. Annu Rev Pathol. 7:353–384.
2012.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Xu Y, Wu J, Liao S and Sun Z: Treating
tuberculosis with high doses of anti-TB drugs: Mechanisms and
outcomes. Ann Clin Microbiol Antimicrob. 16(67)2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Viaggi B, Cangialosi A, Langer M, Olivieri
C, Gori A, Corona A, Finazzi S and Di Paolo A: Tissue penetration
of antimicrobials in intensive care unit patients: A systematic
review-part II. Antibiotics (Basel). 11(1193)2022.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Tong RT, Boucher Y, Kozin SV, Winkler F,
Hicklin DJ and Jain RK: Vascular normalization by vascular
endothelial growth factor receptor 2 blockade induces a pressure
gradient across the vasculature and improves drug penetration in
tumors. Cancer Res. 64:3731–3736. 2004.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Mehrad B, Keane MP and Strieter RM:
Chemokines as mediators of angiogenesis. Thromb Haemost.
97:755–762. 2007.PubMed/NCBI
|
